ViE Awards 2018 Categories

 

The Best Clinical Trial Site OR Network category is open to international trial sites and their network owners

  • Matching clinical development needs through a complete programmatic assessment

  • Supportive of multiple and diverse clinical phase and outcomes trials for vaccines

  • Methods of performance improvement or introduction of new services 

  • Rapid enrolment across a variety of vaccine ranges and outstanding study subject retention

  • Reaching of milestones and final / ongoing outcomes / trials

The Best Contract Research Organization category is open to international CROs

  • The range of services provided in niche and core therapeutic areas 

  • Methods of performance improvement or introduction of new services 

  • Attention to and quality of relationships with clients 

  • Reaching of milestones and final / ongoing outcomes 

  • Building and maintaining existing and long-term partnerships

The Best Contract Manufacturing Organization category is open to international CMOs 

  • The range of services provided in niche and core therapeutic areas 

  • Methods of performance improvement or introduction of new services 

  • Attention to and quality of relationships with clients 

  • Reaching of milestones and final / ongoing outcomes 

  • Building and maintaining existing and long-term partnerships               

The Best Production/Process Development 

  • Demonstration of an ongoing commitment to provide production or process technology globally and in reducing lead times for its customers

  • Demonstration of an end-to-end suite of solutions to customers 

  • Demonstration of outstanding thought leadership in spearheading innovation 

  • Examples of raising the bar of process or production standards 

  • Attention to and quality of relationships with clients

The Best Academic Research Team category is open to research institutes and universities 

  • Candidates addressing current unmet medical needs 

  • Significant potential for vast geographical and market reach 

  • Research possession of a novel mode of action or technology 

  • Progress through pre- / clinical phases and / or study results achieved

  • Details of significant grants ie. donors / amounts achieved supporting research

The Biotech Company of the Year category is open to Chief Executives from all sized Biotechs 

  • Progression of vaccine candidates 

  • Success and application their platform/vaccine technology

  • Commitment to R&D productivity model implementation 

  • Finance secured as well as current and future market potential and value for the pipeline 

The Best Pharma Company category is open to international Pharmaceutical organizations

  • Size and range of the overall vaccine pipeline 

  • Mix across development phases 

  • Spread across innovation and lower risk candidate development 

  • Commitment to R&D productivity model implementation 

  • Current and future market potential and value for the pipeline 

The Best Therapeutic Vaccine (approved or in development) category is open to all vaccine organizations

  • Vaccine candidate addresses current unmet medical needs 

  • Candidate shows significant potential for vast geographical and market reach 

  • Candidate possesses a novel mode of action or technology 

  • Progress made to-date through clinical trials and / or achieved milestones 

  • Advanced efficacy, safety and risk management data where appropriate

The Best Prophylactic Vaccine (approved or in development) category is open to all vaccine organizations 

  • Vaccine candidate addresses current unmet medical needs 

  • Candidate shows significant potential for vast geographical and market reach 

  • Candidate possesses a novel mode of action or technology 

  • Progress made to-date through clinical trials and / or achieved milestones 

  • Advanced efficacy, safety and risk management data where appropriate